BC Platforms appoints Dr Carolin Bender as Chief Medical
ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces...
Source: globenewswire.com
đ° Daniel Gooch News
Page 2 - Daniel Gooch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Gooch. Real-time updates on events, politics, business and more.
TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of its EUR 22 million (approximately USD 23.8 million) round. This follows
Source: finanznachrichten.de
BC Platforms Selected as Partner to Deliver key Singapore Population Health Study
BC Platforms Selected as Partner to Deliver key Singapore Population Health Study First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases GlobeNewswire January 09, 2023 ZURICH, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today...
Source: asiaone.com
BC Platforms Announces Powerful Patient Data Sharing Platform to speed up Biotech R&D Process
BCP's 'Trusted Collaboration Environment (TCE)' is a research infrastructure service and software solution that supports development of novel therapies using industry leading healthcare data
Source: finanznachrichten.de
EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics
/PRNewswire/ -- EnteroBiotix Limited, the premier full-spectrum microbiome therapeutics company, today announced that it has been granted a Manufacturers...
Source: prnewswire.com
EnteroBiotix Appoints David Lawrence to its Board of Directors
/PRNewswire/ -- EnteroBiotix, a biopharmaceutical company developing novel highly-diverse microbial therapeutics that enhance the gut microbiome, today...
Source: prnewswire.com
Valo Therapeutics Appoints Experienced Life Sciences Executive Anthony Giovinazzo to Board
/PRNewswire/ -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced...
Source: prnewswire.com
MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
/PRNewswire/ -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
Source: prnewswire.com
MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
/PRNewswire/ -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
Source: prnewswire.com
MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing.
Source: biospace.com